Press Release
Bezuclastinib combination is first treatment ever to demonstrate statistically significant advantage against active comparator in GIST patients; median PFS of 16.5 months versus 9.2…
LOUISVILLE, Ky., May 02, 2026 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (Nasdaq: CHDN) (the “Company”,…
MONACO CITY, Monaco, May 02, 2026 (GLOBE NEWSWIRE) — AlphaPepe is nearing $1.1 million in…
HIGH POINT, N.C., May 02, 2026 (GLOBE NEWSWIRE) — High Point University celebrated the Class…
New York City, NY, May 02, 2026 (GLOBE NEWSWIRE) — Steel Power has quickly emerged…
New York City, NY, May 02, 2026 (GLOBE NEWSWIRE) — Understanding the amazingly consistent pattern…
New York City, NY, May 02, 2026 (GLOBE NEWSWIRE) — You know that sinking feeling…